BDCRB is a selective Human cytomegalovirus (HCMV) inhibitor through blocking the maturational cleavage of high-molecular-weight DNA. BDCRB shows a mean IC50 of 0.03 µM for viral yield at 72 h postinfection[1].
Molecular Weight:
398.04
CAS Number:
[142356-43-2]
Formula:
C12H11BrCl2N2O4
Target:
CMV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted